Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
CARsgen Presents Data from China Pivotal Phase II Trial of BCMA CAR T Zevor-cel (CT053) at 2022 ASH Annual Meeting 2022-12-12 21:50
PharmAbcine Announces Collaboration Agreement with MSD to Evaluate Anti-VISTA Antibody PMC-309 in Combination with KEYTRUDA® (pembrolizumab) 2022-12-12 21:00
Asieris'Bladder Cancer Diagnostic Drug Hexvix® Completed Dosing of First Patient in Real-World Clinical Study 2022-12-12 20:59
JITC publication of Akeso's Ligufalimab(CD47 monoclonal antibody) mechanism shows promising antitumor efficacy and favorable safety profile 2022-12-12 12:59
HitGen Announces Research Agreement with Nitrase Therapeutics Focused on DNA-Encoded Library Based Drug Discovery 2022-12-12 10:10
Gracell Biotechnologies Presents Clinical Data for FasTCAR-T GC012F for High Risk, Newly Diagnosed Multiple Myeloma Demonstrating 100% Overall Response Rate 2022-12-11 07:15
The 1st Boao International Conference on Real World Studies of Medical Products Held in Hainan 2022-12-09 19:54
Shenzhen Holds 2022 Global Investment Promotion Conference to Build a Magnet for International Investors 2022-12-09 11:16
SK Biopharmaceuticals' Partner Angelini Pharma Launches Cenobamate in France 2022-12-09 06:30
ReviR Therapeutics to Present at RNA Targeted Drug Discovery Summit 2022-12-08 23:00
LISCure's Phase 2 Drug Candidate Granted Orphan Drug Designation (ODD) from US FDA 2022-12-08 22:00
Waterdrop CEO Peng Shen Elected as Vice Chairman of Alumni Association of Zhejiang University-The Hong Kong Polytechnic University Joint Center 2022-12-08 21:30
CABIO Showcases the Latest Research Results and Innovative Solutions at Food Ingredients Europe 2022 2022-12-08 21:00
PharmAbcine to Participate in the 41th Annual J.P. Morgan Healthcare Conference and Biotech Showcase™ 2023 during JPM Week 2022-12-08 21:00
Japanese Healthcare Startup Ubie, Inc. Closes Extended Series C Round at $45 million, Establishes Subsidiary in NY 2022-12-08 16:00
Createrna Announces Positive Top-Line Results from Phase 1 Clinical Trials of QR052107B Tablet in Healthy Volunteers 2022-12-08 14:29
BSR KOREA Introduces "Wizbiosolutions Inc." as "2022 Global Procurement Marketer" 2022-12-08 00:00
Newtown's Apple to Highly Saturated Global Molecular Market, TIANGEN TGuide S16 Automated Nucleic Acid Extractor Showcased at Cell Bio 2022 2022-12-06 21:04
Akeso Inc. Announces Collaboration and License Agreement for Up to US$5 Billion with Summit Therapeutics to Accelerate Global Development and Commercialization of its Breakthrough Bispecific Antibody, Ivonescimab (PD-1/VEGF) 2022-12-06 21:01
Daewoong Pharmaceutical announces success in developing a new antidiabetic medication and its aims to enter the market in over 50 countries by 2030 2022-12-06 20:00
1 124 125 126 127 128 801